Bioscape Scoring Techniques
This document provides examples of some of the adopted and proposed techniques for scoring source and result data in order to more accurately identify bioentities in the literature.
Contents
Confirmation of Mention Suggestions
PubMed #11137999
Method: to be implemented
"Here we report the identification of a new transmembrane serine protease (TMPRSS3; also known as ECHOS1) expressed in many tissues, including fetal cochlea, which is mutated in the families used to describe both the DFNB10 and DFNB8 loci."
( | TMPRSS3 | ; also known as | ECHOS1 | ) |
suggestions | suggestion | |||
TMPRSS3 (#64699) TMPRSS4 (#56649) |
TMPRSS3 (#64699) |
- TMPRSS3 (#64699) occurs for both mentions
- "also known as" could be used as a key to such situations
- close proximity of mentions (as seen with acronyms) could be sufficient
Note that the above also involves an acronym.
PubMed #7479798
Method: confirmed_by_competing_names
"Cloning and analysis of the full-length cDNA of the human CSE1 homologue, which we name CAS for cellular apoptosis susceptibility gene, reveals a protein coding region with similar length (971 amino acids for CAS, 960 amino acids for CSE1) and 59% overall protein homology to the yeast CSE1 protein."
human | CSE1 | homologue, which we name | CAS |
suggestion | suggestions | ||
CSE1L (#1434) | CSE1L (#1434) CTNND1 (#1500) BCAR1 (#9564) |
- CSE1L (#1434) is supported by two different names
- CTNND1 (#1500) and BCAR1 (#9564) are not supported by any other names
- the "which we name" text also confirms the equivalence of the two entities
Finding Unambiguous Gene Mentions
In various disambiguation techniques, an unambiguous gene mention may be needed in order to disambiguate between competing gene suggestions. Consequently, a reliable method is needed to find "high quality" suggestions which can be considered as unambiguous gene mentions. Consider the following document excerpt:
PubMed #9788873
"In mouse embryo fibroblasts, TCDD activates expression of multiple genes, including CYP1B1, the predominant cytochrome P450 expressed in these cells."
Mentions | Suggestions | Methods | |
---|---|---|---|
unambiguous_at_exact_location | not_part_of_other_mentions | ||
CYP1B1 | CYP1B1 (#1545) | X | X |
CYP1 | CYP1A1 (#1543) | ||
CYP2A (#1546) | |||
CYP27B1 (#1594) | |||
CYP | PPIG (#9360) | X |
- Here, CYP1B1 (#1545) can be considered at this location as an unambiguous gene mention.
If the above methods taken together are known as an "unambiguous gene mention" method, the fundamental technique can be defined in terms of this method. However, in order to eliminate obvious bad suggestions for genes, it is also necessary to apply other methods in order to identify good suggestions more reliably.
Disambiguating using Unambiguous Mentions
Within the same document, the presence of unambiguous gene mentions can be used to help disambiguate at other mention locations where an unambiguously identified gene may be "competing" with other genes, typically using a name which is ambiguous. For example:
PubMed #10484773
Method: disambiguated_by_unambiguous_gene_mention
"A common genetic variant (V) of the human luteinizing hormone (LH) beta-subunit gene was recently discovered."
of the | human luteinizing hormone (LH) beta | -subunit gene |
suggestion | ||
LHB (#3972) |
With this unambiguous mention identified and the presence of the suggested gene confirmed, this knowledge can be applied to other mention locations. For example:
"We have now studied whether additional mutations in the V-LHbeta promoter sequence could contribute to the altered physiology of the LH variant molecules."
in the | V-LHbeta | promoter sequence |
suggestions | ||
LHB (#3972) PLOD2 (#5352) LHX2 (#9355) |
Since the latter two genes are not unambiguously identified in the document, yet the first gene has been identified (see above), the latter two genes are scored negatively and are regarded as not being referenced.
Note that the confirmed_by_competing_names method also resolves these mentions.
Gene Ontology Correspondence
PubMed #16566752
"In the present study, we subjected CD1 male mice to intraperitoneal injection with TNFalpha (10 ng/mouse) and then examined the expression and localization of DMT1 (divalent metal transporter 1), IREG1 (iron-regulated protein 1) and ferritin in duodenum."
of | DMT1 | (divalent metal transporter 1), | IREG1 | (iron-regulated protein 1) |
suggestions | suggestion | |||
DMRT1 (#1761) SLC11A2 (#4891) CHMP2B (#25978) |
SLC40A1 (#30061) |
Gene Ontology (Function) correspondence could be used:
DMRT1 | SLC11A2 | CHMP2B | IREG1 | |
(#1761) | (#4891) | (#25978) | (#30061) | |
ferrous iron transmembrane transporter activity | X | |||
iron ion binding | >2 | X | X | |
iron ion transmembrane transporter activity | <1 | X | ||
metal ion binding | X | |||
zinc ion binding | X | X |
- X: exact match
- <1: more specific match: ferrous iron transmembrane transporter activity => iron ion transmembrane transporter activity
- >2: more general match: metal ion binding <= transition metal ion binding <= iron ion binding
Chromosome Information Correspondence
PubMed #10072425
"The t(X;18)(p11.2;q11.2) chromosomal translocation commonly found in synovial sarcomas fuses the SYT gene on chromosome 18 to either of two similar genes, SSX1 or SSX2, on the X chromosome."
the | SYT | gene on | chromosome 18 |
suggestion | information | ||
SS18 (#6760) (chromosome 18) SYT1 (#6857) (chromosome 12) |
chromosome 18 |
- SS18 chromosome matches the accompanying information.
- Note that "X chromosome" is also mentioned in the sentence.